Socioeconomic Status Linked With Stroke

Adjusted gross domestic product and health expenditures are associated with incidence of stroke and 30-day stroke mortality, as well as age at onset of stroke and proportion of intracerebral hemorrhages, according to the results of a new study. Heartwire

Over Time, Even Low Alcohol Use Ups Breast Cancer Risk

A large study published in JAMA indicates that the effect of regularly drinking modest amounts of alcohol adds up over the years. Medscape Medical News

More Deaths From Opioids Than Cocaine, Heroin Combined

A CDC report shows that America’s prescription drug problem has reached epidemic proportions. Medscape Medical News

Depression: Don’t Ask, Don’t Tell?

In up to 25% of primary care patients with depression, the condition is not diagnosed. Why might this be? Medscape Psychiatry

No Evidence ADHD Meds Increase Cardiovascular Risk

A large cohort study shows current use of ADHD medications does not increase the cardiovascular risk in children and young adults. Medscape Medical News

Economics at Heart of Drug Shortages

WASHINGTON (MedPage Today) — The Obama administration’s plan to deal with current and future drug shortages got a lukewarm reception from several observers with knowledge of the problem.

Home HPV Tests Good Bet for Poor Nations (CME/CE)

(MedPage Today) — In poor or developing countries, home-based sampling for human papillomavirus could pick up many cases of cervical lesions and cancer that would otherwise be missed, researchers suggested.

Isis commences ISIS-GCGRRx and ISIS-GCCRRx Phase 1 studies for type 2 diabetes

Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.

PSTC, FNIH Biomarkers Consortium launch clinical study to improve detection of kidney injury

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.

Targeted antibiotic safe and effective for irritable bowel syndrome

Among the most commonly used treatments for irritable bowel syndrome - which affects as many as 20 percent of the United States population - a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials.